Results 161 to 170 of about 16,185,394 (397)

The clinical utility of tuberculin skin tests: a single-center experience. [PDF]

Colomb Med (Cali), 2022
Üzer F, Öner Ş, Gokmen Y, Yeşil Ö, Özdemir T.   +4 more
europepmc   +1 more source

Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment

Arthritis Care &Research, EarlyView.
Objective Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to identify biomarkers of histologic features and treatment response.
Andrea Fava, Catriona A. Wagner, Carla J. Guthridge, Susan Macwana, Wade DeJager, Melissa E. Munroe, Peter Izmirly, H. Michael Belmont, Betty Diamond, Anne Davidson, Paul J. Utz, Michael H. Weisman, Philip M. Carlucci, Maria Dall'Era, Kenneth Kalunian, Chaim Putterman, Jennifer Anolik, Jennifer L. Barnas, David Wofsy, Diane Kamen, Richard A. Furie, Deepak A. Rao, the Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus Network, Chun‐Hao Lee, Derek Fine, Manny Monroy‐Trujillo, Ummara Shah, Mariko Ishimori, Robert M. Clancy, Michael Belmont, Ming Wu, Nicole Bornkamp, Evan Der, Beatrice Goilav, Nicole Jordan, Daniel Schwartz, James Pullman, David Wofsy, Dawn Smilek, Patti Tosta, Matthias Kretzler, Celine C. Berthier, E. Steve Woodle, Dave Hildeman, Michael Brenner, Michelle Petri, Joel M. Guthridge, Jill Buyon, Judith A. James   +48 more
wiley   +1 more source

Lack of Leukocyte Migration Inhibition by Hepatitis B Antigen and Normal Nonspecific Immunoreactivity in Asymptomatic Carriers [PDF]

, 2017
The immune response to hepatitis B surface antigen (RBs Ag) was studied in 25 asymptomatic carriers by the leukocyte migration-inhibition (LMI) test in agarose.
Desaules, M., Frei, P. C., Libanska, J., Wuilleret, B.   +3 more
core  

Skin prick test in milk allergic patients undergoing oral immunotherapy: Does the milk form used for skin tests matter? [PDF]

Front Allergy, 2022
Bukhari E, Gabrielli S, McCusker C, Upton J, Grunebaum E, Chan ES, Beaudette L, Langlois A, Torabi B, Lejtenyi D, Clarke AE, Ke D, Mazer BD, Ben-Shoshan M.   +13 more
europepmc   +1 more source

Effectiveness of Virtual Reality for Pediatric Pain and Anxiety Management during Skin Prick Testing

, 2022
Céline Stassart, Karin Giebels
openalex   +2 more sources

Assessment of skin in patients with systemic sclerosis using high‐frequency ultrasound and shear wave elastography: A comparative study with histology, molecular and clinical parameters

Arthritis Care &Research, Accepted Article.
Objective Ultrasound (US) has been proposed as a potential tool for assessing skin fibrosis in systemic sclerosis (SSc). However, a large‐scale comparison of US‐based assessment with histological markers of skin fibrosis has not been reported. We evaluated the US‐based skin assessments for their face validity (differentiation between involved SSc and ...
Ruhani Desai, Filemon Tan, Minghua Wu, Jeffery L. Browning, Samuel Theodore, Meng Zhang, Brian Skaug, Harshdeep Singh Chawla, Manmohan Singh, Salavat Aglyamov, Kirill V. Larin, Maureen Mayes, Shervin Assassi   +12 more
wiley   +1 more source

Peri-operative anaphylaxis in Coimbra: the experience of our drug allergy clinic [PDF]

, 2008
Background: The incidence of peri-operative anaphylactic reactions ranges from 1:10,000 to 1:20,000. It is crucial to identify the risk factors, the trigger agent and to fi nd adequate alternatives.
Chieira, C, Faria, E, Geraldes, L, Santos, A, Sousa, N   +4 more
core  

Intracutaneous Skin Tests and Serum IgE Levels Cannot Predict the Grade of Anaphylaxis in Patients with Insect Venom Allergies. [PDF]

J Asthma Allergy, 2022
Hollstein MM, Matzke SS, Lorbeer L, Forkel S, Fuchs T, Lex C, Buhl T.   +6 more
europepmc   +1 more source

Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface [PDF]

, 2014
Kadri Orro, Olga Smirnova, Jelena Arshavskaja, Kristiina Salk, Anne Meikas, Susan Pihelgas, Reet Rumvolt, Külli Kingo, Aram Kazarjan, Toomas Neuman, Pieter Spee   +10 more
openalex   +1 more source

Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue–Related Raynaud Phenomenon in the United States

Arthritis Care &Research, EarlyView.
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech, Charles G. Frech, W. David Merryman, Andrew Sternlicht, Justin Baba   +4 more
wiley   +1 more source